Dashboard
Manage Tickers

OGN Organon & Co.

NYSE organon.com


$ 9.43 $ -0.12 (-1.26 %)    

Tuesday, 14-Oct-2025 11:30:14 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 597.06 $ 1.84 (0.31 %)
DIA $ 460.25 $ 3.25 (0.71 %)
SPY $ 659.93 $ 2.64 (0.4 %)
TLT $ 90.52 $ -0.12 (-0.13 %)
GLD $ 380.77 $ 2.42 (0.64 %)
$ 9.6
$ 9.52
$ 9.42 x 301
$ 9.44 x 1,036
$ 9.41 - $ 9.53
$ 7.99 - $ 18.29
3,150,702
na
2.5B
$ 0.43
$ 3.57
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-02-2025 03-31-2025 10-Q
3 02-28-2025 12-31-2024 10-K
4 11-01-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-03-2024 03-31-2024 10-Q
7 02-26-2024 12-31-2023 10-K
8 11-03-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-05-2023 03-31-2023 10-Q
11 02-27-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 03-21-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 06-21-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

henlius-and-organon-secure-european-commission-approval-for-bildyos-and-bilprevda-denosumab-biosimilars-to-prolia-and-xgeva-covering-all-indications-across-eu
Henlius And Organon Secure European Commis...
09/19/2025 10:03:36

fda-approves-henlius-and-organons-bildyos-and-bilprevda-biosimilars-to-amgens-prolia-and-xgeva-expanding-us-bone-health-treatment-options
FDA Approves Henlius And Organon's BILDYOS...
09/02/2025 09:37:57

organon-raises-fy2025-sales-guidance-from-6125b-6325b-to-6275b-6375b-vs-6223b-est
Organon Raises FY2025 Sales Guidance from ...
08/05/2025 11:31:12

Organon (NYSE:OGN) raises FY2025 sales outlook from $6.125 billion-$6.325 billion to $6.275 billion-$6.375 billion vs $6.223 bi...

organon-q2-adj-eps-100-beats-094-estimate-sales-1594b-beat-1552b-estimate
Organon Q2 Adj. EPS $1.00 Beats $0.94 Esti...
08/05/2025 11:30:45

Organon (NYSE:OGN) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.94 by 6.84 pe...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

a-look-ahead-organons-earnings-forecast
A Look Ahead: Organon's Earnings Forecast
08/04/2025 16:02:32

Core News & Articles
Live On CNBC, Jenny Harrington Announces S...
07/08/2025 16:50:07

organons-vtama-granted-strong-recommendation-by-american-academy-of-dermatology-in-updated-2025-guidelines-for-adult-atopic-dermatitis
Organon's VTAMA Granted Strong Recommendat...
07/07/2025 11:32:56

organons-phase-2-elena-proof-of-concept-study-of-og-6219-in-endometriosis-related-pain-did-not-meet-its-primary-efficacy-endpoint-discontinues-the-og-6219-clinical-development-program
Organon's Phase 2 Elena Proof-of-concept S...
07/02/2025 11:33:14

Organon (NYSE:OGN), a global healthcare company with a focus on women's health, today announced that the Phase 2 ELENA proo...

organons-phase-2-elena-proof-of-concept-study-evaluating-og-6219-did-not-meet-primary-efficacy-endpoint
Organon's Phase 2 ELENA Proof-of-Concept S...
07/02/2025 11:31:09

easy-income-portfolio-june-2025-update
Easy Income Portfolio: June 2025 Update
06/16/2025 14:20:25

samsung-bioepis-and-organon-say-fda-designates-hadlima-high--and-low-concentration-autoinjectors-and-high-concentration-prefilled-syringe-as-interchangeable-biosimilars-to-humira
Samsung Bioepis And Organon Say FDA Design...
05/27/2025 11:32:12

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentrati...

piper-sandler-maintains-overweight-on-organon-lowers-price-target-to-18
Piper Sandler Maintains Overweight on Orga...
05/15/2025 16:15:02

Piper Sandler analyst David Amsellem maintains Organon (NYSE:OGN) with a Overweight and lowers the price target from $24 to ...

morgan-stanley-maintains-equal-weight-on-organon-lowers-price-target-to-10
Morgan Stanley Maintains Equal-Weight on O...
05/05/2025 14:38:26

Morgan Stanley analyst Terence Flynn maintains Organon (NYSE:OGN) with a Equal-Weight and lowers the price target from $15 t...

dow-surges-over-300-points-mcdonalds-posts-weak-revenue
Dow Surges Over 300 Points; McDonald's Pos...
05/01/2025 17:16:40

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/01/2025 17:06:57

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/01/2025 12:05:58

organons-board-of-directors-cuts-quarterly-dividend-to-002-per-share-down-from-028-per-share-company-resets-capital-allocation-priorities-to-accelerate-progress-towards-deleveraging-new-annual-regular-dividend-rate-of-008-per-share
Organon's Board Of Directors Cuts Quarterl...
05/01/2025 11:28:28

 The dividend is payable on June 12, 2025, to stockholders of record at the close of business on May 12, 2025. 

organon-affirms-fy2025-sales-guidance-of-613b-633b-vs-623b-est
Organon Affirms FY2025 Sales Guidance of $...
05/01/2025 11:21:34

Full year 2025 financial guidance is presented below on a non-GAAP basis, except revenue.  Previous Guidance as of February 13,...

organon-q1-2025-adj-eps-102-beats-090-estimate-sales-151b-inline
Organon Q1 2025 Adj. EPS $1.02 Beats $0.90...
05/01/2025 11:04:13

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION